Pathophysiology and Management of Hypoglycemiain End-Stage Renal Disease Patients: A Review

Fischer, 1986, Hypoglycemia in hospitalized patients. Causes and outcomes, N Engl J Med, 315, 1245, 10.1056/NEJM198611133152002

Arem, 1989, Hypoglycemia associated with renal failure, Endocrinol Metab Clin North Am, 18, 103, 10.1016/S0889-8529(18)30391-8

Moen, 2009, Frequency of hypoglycemia and its significance in chronic kidney disease, Clin J Am Soc Nephrol, 4, 1121, 10.2215/CJN.00800209

de Boer, 2011, Temporal trends in the prevalence of diabetic kidney disease in the United States, JAMA, 305, 2532, 10.1001/jama.2011.861

Stumvoll, 1999, Important role of the kidney in human carbohydrate metabolism, Med Hypotheses, 52, 363, 10.1054/mehy.1997.0655

Adrogué, 1992, Glucose homeostasis and the kidney, Kidney Int, 42, 1266, 10.1038/ki.1992.414

Stumvoll, 1998, Glucose production by the human kidney--its importance has been underestimated, Nephrol Dial Transplant, 13, 2996, 10.1093/ndt/13.12.2996

Duckworth, 1981, Insulin metabolism and degradation, Endocr Rev, 2, 210, 10.1210/edrv-2-2-210

Ferrannini, 1983, Splanchnic and renal metabolism of insulin in human subjects: a dose-response study, Am J Physiol, 244, E517

Rabkin, 1984, The renal metabolism of insulin, Diabetologia, 27, 351, 10.1007/BF00304849

Iglesias, 2008, Insulin therapy in renal disease, Diabetes Obes Metab, 10, 811, 10.1111/j.1463-1326.2007.00802.x

Mak, 1992, Glucose and insulin metabolism in uremia, Nephron, 61, 377, 10.1159/000186953

Guarnieri, 2009, Insulin resistance in chronic uremia, J Ren Nutr, 19, 20, 10.1053/j.jrn.2008.11.014

Mak, 2000, Impact of end-stage renal disease and dialysis on glycemic control, Semin Dial, 13, 4, 10.1046/j.1525-139x.2000.00007.x

Kovesdy, 2010, Glycemic control and burnt-out diabetes in ESRD, Semin Dial, 23, 148, 10.1111/j.1525-139X.2010.00701.x

Ramirez, 1986, The role of glucose in hemodialysis: the effects of glucose-free dialysate, Am J Kidney Dis, 7, 413, 10.1016/S0272-6386(86)80091-9

Jackson, 2000, Hemodialysis-induced hypoglycemia in diabetic patients, Clin Nephrol, 54, 30

Jackson, 1999, Occult hypoglycemia caused by hemodialysis, Clin Nephrol, 51, 242

Sharma, 2008, Glucose in the dialysate: historical perspective and possible implications?, Hemodial Int, 12, 221, 10.1111/j.1542-4758.2008.00256.x

Burmeister, 2007, Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis, Nephrol Dial Transplant, 22, 1184, 10.1093/ndt/gfl710

Loipl, 2005, Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients, Ren Fail, 27, 305, 10.1081/JDI-56608

Takahashi, 2004, The mechanism of hypoglycemia caused by hemodialysis, Clin Nephrol, 62, 362, 10.5414/CNP62362

Stevenson, 2013, In vitro glucose kinetics during continuous renal replacement therapy: implications for caloric balance in critically ill patients, Int J Artif Organs, 36, 861, 10.5301/ijao.5000232

Abe, 2008, The influence of hemodialysis membranes on the plasma insulin level of diabetic patients on maintenance hemodialysis, Clin Nephrol, 69, 354, 10.5414/CNP69354

Blake, 2009, Icodextrin: fifteen years and counting, Perit Dial Int, 29, 367, 10.1177/089686080902900401

Workgroup on Hypoglycemia, 2005, Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia, Diabetes Care, 28, 1245, 10.2337/diacare.28.5.1245

Moghissi, 2009, American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control, Diabetes Care, 32, 1119, 10.2337/dc09-9029

American Diabetes Association, 2017, Glycemic targets, Diabetes Care, 40, S48, 10.2337/dc17-S009

Ramirez, 1988, Counter-regulatory hormonal response to insulin-induced hypoglycemia in patients on chronic hemodialysis, Nephron, 49, 231, 10.1159/000185061

Mendoza-Hernández, 2000, Aggregation, dissociation and unfolding of glucose dehydrogenase during urea denaturation, Biochim Biophys Acta, 1478, 221, 10.1016/S0167-4838(00)00025-X

Mehmet, 2001, Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis, Diabet Med J Br Diabet Assoc, 18, 679, 10.1046/j.0742-3071.2001.00556.x

Clark, 1991, Are blood glucose reagent strips reliable in renal failure?, Diabet Med, 8, 168, 10.1111/j.1464-5491.1991.tb01565.x

Wens, 1998, A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer, Perit Dial Int, 18, 603, 10.1177/089686089801800608

Janssen, 1998, Positive interference of icodextrin metabolites in some enzymatic glucose methods, Clin Chem, 44, 2379, 10.1093/clinchem/44.11.2379

Qayyum, 2016, Use of continuous glucose monitoring in patients with diabetes mellitus on peritoneal dialysis: correlation with glycated hemoglobin and detection of high incidence of unaware hypoglycemia, Blood Purif, 41, 18, 10.1159/000439242

Haviv, 2000, Hypoglycemia in patients with renal failure, Ren Fail, 22, 219, 10.1081/JDI-100100866

Tzamaloukas, 1993, The relationship between glycemic control and morbidity and mortality for diabetics on dialysis, ASAIO J, 39, 880, 10.1097/00002480-199339040-00011

National Kidney Foundation, 2012, KDOQI clinical practice guideline for diabetes and CKD: 2012 update, Am J Kidney Dis, 60, 850, 10.1053/j.ajkd.2012.07.005

Ricks, 2012, Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study, Diabetes, 61, 708, 10.2337/db11-1015

Adler, 2014, Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.K, Diabetes Care, 37, 1304, 10.2337/dc13-0553

Kalantar-Zadeh, 2007, A1C and survival in maintenance hemodialysis patients, Diabetes Care, 30, 1049, 10.2337/dc06-2127

Shurraw, 2011, Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study, Arch Intern Med, 171, 1920, 10.1001/archinternmed.2011.537

Gallagher, 2009, Review of hemoglobin A1c in the management of diabetes, J Diabetes, 1, 9, 10.1111/j.1753-0407.2009.00009.x

Koga, 2010, Clinical impact of glycated albumin as another glycemic control marker, Endocr J, 57, 751, 10.1507/endocrj.K10E-138

Armbruster, 1987, Fructosamine: structure, analysis, and clinical usefulness, Clin Chem, 33, 2153, 10.1093/clinchem/33.12.2153

Peacock, 2008, Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis, Kidney Int, 73, 1062, 10.1038/ki.2008.25

Inaba, 2007, Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection, J Am Soc Nephrol, 18, 896, 10.1681/ASN.2006070772

Nunoi, 1991, Comparison of reliability of plasma fructosamine and glycosylated hemoglobin assays for assessing glycemic control in diabetic patients on hemodialysis, Metabolism, 40, 986, 10.1016/0026-0495(91)90077-A

Joy, 2002, Long-term glycemic control measurements in diabetic patients receiving hemodialysis, Am J Kidney Dis, 39, 297, 10.1053/ajkd.2002.30549

Lee, 2013, Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients, PLoS One, 8, e57762, 10.1371/journal.pone.0057762

Shafi, 2013, Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients, Diabetes Care, 36, 1522, 10.2337/dc12-1896

Freedman, 2011, Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients, Clin J Am Soc Nephrol, 6, 1635, 10.2215/CJN.11491210

Garber, 1974, Hypoglycemia in compensated chronic renal insufficiency. Substrate limitation of gluconeogenesis, Diabetes, 23, 982, 10.2337/diab.23.12.982

Sun, 2009, Hypoglycemia in diabetic patients undergoing chronic hemodialysis, Ther Apher Dial, 13, 95, 10.1111/j.1744-9987.2009.00662.x

Benner, 2016, In-center nutrition practices of clinics within a large hemodialysis provider in the United States, Clin J Am Soc Nephrol, 11, 770, 10.2215/CJN.09270915

Sobngwi, 2010, Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis, Diabetes Care, 33, 1409, 10.2337/dc09-2176

Toyoda, 2012, Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis, J Nephrol, 25, 989, 10.5301/jn.5000081

Marchant, 2002, The renal diabetic nurse specialist...a luxury or an essential player?, EDTNA ERCA J, 28, 67, 10.1111/j.1755-6686.2002.tb00204.x

Bouchi, 2011, Administration of insulin glargine thrice weekly by medical staff at a dialysis unit: a new insulin regimen for diabetic management in physically impaired patients undergoing hemodialysis, Diabetol Int, 2, 197, 10.1007/s13340-011-0044-9

Toujeo prescribing information. Sanofi-Aventis; 2015. Available at: http://products.sanofi.us/toujeo/toujeo.pdf. Accessed January 18, 2017.

Lantus prescribing information. Sanofi-Aventis; 2015. Available at: http://products.sanofi.us/lantus/lantus.html. Accessed January 18, 2017.

Jacobsen, 2002, Pharmacokinetics of insulin detemir in subjects with renal or hepatic impairment, Diabetologia, 45, A259

Kiss, 2014, Insulin degludec: pharmacokinetics in patients with renal impairment, Clin Pharmacokinet, 53, 175, 10.1007/s40262-013-0113-2

Aisenpreis, 1999, Pharmacokinetics and pharmacodynamics of insulin Lispro compared with regular insulin in haemodialysis patients with diabetes mellitus, Nephrol Dial Transplant, 14, 5, 10.1093/ndt/14.suppl_4.5

Kulozik, 2013, Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?, Ther Adv Endocrinol Metab, 4, 113, 10.1177/2042018813501188

Holmes, 2005, Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment, Br J Clin Pharmacol, 60, 469, 10.1111/j.1365-2125.2005.02476.x

Apidra prescribing information. Sanofi-Aventis; 2015. Available at: http://products.sanofi.us/apidra/apidra.html. Accessed January 18, 2017.

Sandler, 2014, Reducing the risk of hypoglycemia associated with intravenous insulin: experience with a computerized insulin infusion program in 4 adult intensive care units, J Diabetes Sci Technol, 8, 923, 10.1177/1932296814540870

Almalki, 2012, Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials, Clin Invest Med, 35, E132, 10.25011/cim.v35i3.16589

Sterns, 2016, Treatment of hyperkalemia: something old, something new, Kidney Int, 89, 546, 10.1016/j.kint.2015.11.018

Inoue, 2003, Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure, Clin Nephrol, 60, 90, 10.5414/CNP60090

Hasslacher, 2003, Multinational Repaglinide Renal Study Group. Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function, Diabetes Care, 26, 886, 10.2337/diacare.26.3.886

Schwartz, 2015, Effects of TZD use and discontinuation on fracture rates in ACCORD bone study, J Clin Endocrinol Metab, 100, 4059, 10.1210/jc.2015-1215

McGill, 2013, Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment, Diabetes Care, 36, 237, 10.2337/dc12-0706

Ito, 2013, Vildagliptin is effective for glycemic control in diabetic patients undergoing either hemodialysis or peritoneal dialysis, Diabetes Ther, 4, 321, 10.1007/s13300-013-0029-8

Ferreira, 2013, Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency, Diabetes Care, 36, 1067, 10.2337/dc12-1365

Yoshida, 2016, Switching from subcutaneous insulin injection to oral vildagliptin administration in hemodialysis patients with type 2 diabetes: a pilot study, Int Urol Nephrol, 48, 1349, 10.1007/s11255-016-1305-0

Umpierrez, 2013, Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study, Diabetes Care, 36, 3430, 10.2337/dc13-0277

Gonzalez, 2007, Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure, Endocr Pract, 13, 417, 10.4158/EP.13.4.417

McLaughlin, 2000, Octreotide: an antidote for sulfonylurea-induced hypoglycemia, Ann Emerg Med, 36, 133, 10.1067/mem.2000.108183